ELECSYS FT4 IV
Report
- Report Number
- 1823260-2023-03453
- Event Type
- Malfunction
- Date Received
- October 30, 2023
- Date of Event
- September 4, 2023
- Report Date
- August 29, 2024
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- CEC
- UDI-DI
- 07613336172780
- PMA / PMN Number
- K220456
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE SERIAL NUMBER OF THE CUSTOMER'S COBAS E 801 MODULE IS (B)(6). THE INVESTIGATION IS ONGOING.
THE INVESTIGATION REVIEWED THE CALIBRATIONS; THE RESULTS WERE WITHIN SPECIFICATIONS. THE INVESTIGATION REVIEWED THE QC DATA; THE QC RESULTS WERE WITHIN SPECIFICATIONS. A GENERAL REAGENT ISSUE CAN MOST LIKELY BE EXCLUDED BASED ON THE CALIBRATION AND QC RESULTS. THE INVESTIGATION DETERMINED THE EVENT WAS CONSISTENT WITH A PREANALYTIC ISSUE (PIPETTING OF AN INSUFFICIENT AMOUNT OF SAMPLE OR FOAM/AIR BUBBLES ON THE SAMPLE SURFACE) AT THE CUSTOMER SITE. PREANALYTICS ARE WITHIN THE CUSTOMER'S RESPONSIBILITY. THERE WAS NO INDICATION OF A DEVICE MALFUNCTION.
UDI RELATED DATA QUALITY UPDATES ONLY D3: IS THE INITIAL DISTRIBUTOR IN THE US.
THE INITIAL REPORTER RECEIVED QUESTIONABLE ELECSYS TSH AND ELECSYS FT4 IV RESULTS FROM ONE PATIENT SAMPLE TESTED ON THE COBAS E 801 MODULE. THIS MDR IS FOR THE FT4 IV ASSAY. PLEASE REFER TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR THE TSH ASSAY. THE INITIAL RESULTS WERE REPORTED TO THE DOCTOR. ON (B)(6) 2023, THE INITIAL FT4 RESULT WAS 0.968 PMOL/L. THIS RESULT WAS REPORTED AS 1.31 PMOL/L (THE LIMIT OF QUANTIFICATION LOQ OF THE ASSAY). ON (B)(6) 2023, THE REPEAT RESULT WAS 16.4 PMOL/L.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1851454 | ELECSYS FT4 IV | FREE THYROXINE | CEC | ROCHE DIAGNOSTICS | 09043284190 | 67063401 | 07613336172780 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |